Document Detail

Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar.
MedLine Citation:
PMID:  21451207     Owner:  NLM     Status:  In-Data-Review    
The aim of the study was to define the effect of pharmacological doses of melatonin, an agent known to be a scavenger of reactive oxygen species, on the extracellular matrix composition (glycosaminoglycans and collagen) in the infarcted heart scar. Rats were administered with melatonin at doses of 300 μg/100 g b.w. or 3 mg/100 g b.w. once daily (between 5:00 and 6:00 in the afternoon) or with 1.5 mg/100 g b.w. twice daily (between 8:00 and 9:00 in the morning and additionally between 5:00 and 6:00 in the afternoon). The levels of collagen, glycosaminoglycans (GAG) and some oxidative stress markers (lipid oxidation, the content of sulphydryl groups in proteins and glutathione) were evaluated. In the second part of the experiment, cells were isolated from the scar, identified as myofibroblasts, cultured and treated with melatonin at concentrations ranging from 10(-7)M to 10(-10)M. The pineal indoleamine was seen to reduce the GAG content of the scar, while the collagen content of the scar remained unchanged. A 10(-7)M concentration of melatonin caused an increase in the GAG level in the myofibroblast cultures, while lower concentrations (10(-8)M-10(-10)M) of pineal indoleamine were not effective. Melatonin decreased lipid oxidation and increased the sulphydryl groups of total proteins and glutathione, which suggests its antioxidative activity in the applied doses. The present study shows that pharmacological doses of melatonin reduce the GAG level in an infarcted heart scar. Since the mechanism of GAG content reduction cannot be explained by direct action of the pineal indoleamine on myofibroblasts in the myocardial infarction scar, we hypothesise that changes in GAG content could be indirectly induced by melatonin, that is caused by changes in regulatory systems or reduction of the inflammatory reaction in the area of the infarction. In addition, this paper shows that long-term treatment with melatonin of rats affected by myocardial infarction may reduce oxidative stress in the infarction area.
J Drobnik; D Slotwinska; S Olczak; D Tosik; A Pieniazek; K Matczak; A Koceva-Chyla; A Szczepanowska
Related Documents :
22402067 - An update on cardioprotection: a review of the latest adjunctive therapies to limit myo...
17933857 - Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of respons...
22624277 - Approach to stemi and nstemi.
22230147 - Transradial versus transfemoral intervention for acute myocardial infarction: a propens...
2382607 - Recovery of regional myocardial dysfunction after successful coronary angioplasty early...
20939037 - All comers 5 french transfemoral percutaneous coronary intervention without sheath.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society     Volume:  62     ISSN:  1899-1505     ISO Abbreviation:  J. Physiol. Pharmacol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-03-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114501     Medline TA:  J Physiol Pharmacol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  29-35     Citation Subset:  IM    
Department of Connective Tissue Metabolism, Medical University of Lodz, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Regulation of the expression of cyclooxygenases and production of prostaglandin I? and E? in human c...
Next Document:  Alpha-ketoglutarate stabilizes redox homeostasis and improves arterial elasticity in aged mice.